Acetylator status and tolerance of high-dose trimethoprim-sulfamethoxazole therapy among patients infected with human immunodeficiency virus.
作者信息
Smith C L, Brown I, Torraca B M
机构信息
College of Pharmacy, Department of Pharmacy Practice, Ferris State University, Big Rapids, Michigan, USA.
出版信息
Clin Infect Dis. 1997 Dec;25(6):1477-8. doi: 10.1086/516993.
DOI:10.1086/516993
PMID:9431404
Abstract
摘要
相似文献
1
Acetylator status and tolerance of high-dose trimethoprim-sulfamethoxazole therapy among patients infected with human immunodeficiency virus.
Clin Infect Dis. 1997 Dec;25(6):1477-8. doi: 10.1086/516993.
2
Low-dose dapsone, co-trimoxazole, and survival in Pneumocystis carinii primary prophylaxis.
AIDS. 1996 Aug;10(9):1046-7. doi: 10.1097/00002030-199610090-00020.
3
Successful desensitization of two patients who previously developed Stevens-Johnson syndrome while receiving trimethoprim-sulfamethoxazole.
Clin Infect Dis. 1997 Dec;25(6):1480. doi: 10.1086/516995.
4
Acute delirium induced by intravenous trimethoprim-sulfamethoxazole therapy in a patient with the acquired immunodeficiency syndrome.
Hum Exp Toxicol. 2000 Feb;19(2):149-51. doi: 10.1191/096032700678815666.
5
Drug monitoring during the treatment of AIDS-associated Pneumocystis carinii pneumonia with trimethoprim-sulfamethoxazole.
J Clin Pharm Ther. 1998 Apr;23(2):149-54. doi: 10.1046/j.1365-2710.1998.00152.x.
6
Comparison of three regimens for treatment of mild to moderate Pneumocystis carinii pneumonia in patients with AIDS. A double-blind, randomized, trial of oral trimethoprim-sulfamethoxazole, dapsone-trimethoprim, and clindamycin-primaquine. ACTG 108 Study Group.
Ann Intern Med. 1996 May 1;124(9):792-802. doi: 10.7326/0003-4819-124-9-199605010-00003.
7
Tremor caused by trimethoprim-sulfamethoxazole in a patient with AIDS.
Neurology. 1997 Feb;48(2):537-8. doi: 10.1212/wnl.48.2.537-a.
8
Severe and long lasting cholestasis after high-dose co-trimoxazole treatment for Pneumocystis pneumonia in HIV-infected patients--a report of two cases.
Int J Infect Dis. 2009 Nov;13(6):e467-9. doi: 10.1016/j.ijid.2008.12.016. Epub 2009 Mar 18.
9
Lower bacterial infections with TMP/SMX.
AIDS Patient Care STDS. 1998 Apr;12(4):319. doi: 10.1089/apc.1998.12.319.
10
Adverse reactions to trimethoprim-sulfamethoxazole.
Clin Rev Allergy Immunol. 1996;14(4):451-5. doi: 10.1007/BF02771757.
引用本文的文献
1
Hepatic expression profiles in retroviral infection: relevance to drug hypersensitivity risk.
Pharmacol Res Perspect. 2017 Apr 26;5(3):e00312. doi: 10.1002/prp2.312. eCollection 2017 Jun.
2
Immunogenicity of trimethoprim/sulfamethoxazole in a macaque model of HIV infection.
Toxicology. 2016 Aug 10;368-369:10-18. doi: 10.1016/j.tox.2016.08.010. Epub 2016 Aug 23.
3
Multicenter study of trimethoprim/sulfamethoxazole-related hepatotoxicity: incidence and associated factors among HIV-infected patients treated for Pneumocystis jirovecii pneumonia.
PLoS One. 2014 Sep 3;9(9):e106141. doi: 10.1371/journal.pone.0106141. eCollection 2014.
Zotero 插件